AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 20

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 99.04 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019975SelankHJHJ-2507-F7054PeptideMeter2025-Q399.208.21—Buyer-sourced0PASS
AX-2025-019641RetatrutideTFCTFC-2508-L1799VendorInvestigate2025-Q398.774.77—Buyer-sourced0PASS
AX-2025-019574TirzepatideTFCTFC-2507-T1116VendorInvestigate2025-Q397.193.75101.9Buyer-sourced1FAIL
AX-2025-019291IpamorelinAMBAMB-2505-J6078Janoshik2025-Q399.505.06103.8Buyer-sourced0PASS
AX-2025-018654MK-677 (Ibutamoren mesylate)QSCQSC-2507-F5673PeptideMeter2025-Q399.794.78105.4Buyer-sourced1FAIL
AX-2025-020583TirzepatideSSASSA-2502-D7226Kestrel2025-Q399.047.10104.9Supplier-supplied1MARGINAL
AX-2025-020142MOTS-cERPERP-2508-M9453Janoshik2025-Q399.002.34—Supplier-supplied1FAIL
AX-2025-019936SemaglutideHJHJ-2507-Y6433VendorInvestigate2025-Q398.453.15—Buyer-sourced0PASS
AX-2025-019839SemaglutideHomopeptideHOMO-2506-M5731Janoshik2025-Q398.106.4595.7Buyer-sourced1MARGINAL
AX-2025-019325SemaglutideAMBAMB-2503-S5891Kestrel2025-Q399.935.86—Buyer-sourced1FAIL
AX-2025-019320TirzepatideAMBAMB-2504-P6263Kestrel2025-Q399.535.14101.2Buyer-sourced0PASS
AX-2025-018877SemaglutideTFSTFS-{CAT}-8947Janoshik2025-Q398.915.78—Buyer-sourced0PASS
AX-2025-018521MazdutideWWBWWB-2503-Y3157Janoshik2025-Q399.385.45—Buyer-sourced0PASS
AX-2025-020694SermorelinSGNSGN-2502-Y8340PeptideMeter2025-Q398.715.14—Buyer-sourced0PASS
AX-2025-019242SS-31 (Elamipretide)AMBAMB-2505-V5343Janoshik2025-Q399.362.9891.1Buyer-sourced0PASS
AX-2025-018861KPVFGPFGP-2506-L8855PeptideMeter2025-Q399.674.58—Buyer-sourced0FAIL
AX-2025-021138TirzepatideSIGSIG-2505-6162Janoshik2025-Q398.754.84—Buyer-sourced0PASS
AX-2025-020879BPC-157WXTWXT-2506-M1881Janoshik2025-Q399.233.10100.4Supplier-supplied0PASS
AX-2025-019620BPC-157TFCTFC-2508-W1453Janoshik2025-Q399.813.69103.9Buyer-sourced0PASS
AX-2025-019293IpamorelinAMBAMB-2505-J6078PeptideMeter2025-Q399.544.8598.2Buyer-sourced0PASS
AX-2025-020777SS-31 (Elamipretide)CPCCPC-2504-E9752PeptideMeter2025-Q399.934.23—Supplier-supplied0PASS
AX-2025-020535SemaglutideSSASSA-2502-U6907Janoshik2025-Q397.645.41—Buyer-sourced0PASS
AX-2025-019627NAD+TFCTFC-2505-C1792Janoshik2025-Q399.4411.52104.5Buyer-sourced1FAIL
AX-2025-019440MOTS-cJEEPJEEP-2507-W7622Janoshik2025-Q399.654.61—Buyer-sourced1MARGINAL
AX-2025-018650MK-677 (Ibutamoren mesylate)QSCQSC-2507-F5673Janoshik2025-Q399.614.34—Buyer-sourced1FAIL
AX-2025-020748SemaglutideSGNSGN-2502-F9009Janoshik2025-Q399.045.51101.0Buyer-sourced1MARGINAL
AX-2025-019991SemaglutideSWBSWB-2504-Y6911PeptideMeter2025-Q398.953.0096.3Buyer-sourced0PASS
AX-2025-019876TB-500HJHJ-2502-U5979Nordanalyt2025-Q399.742.90—Buyer-sourced0PASS
AX-2025-019584TirzepatideTFCTFC-2508-G1453VendorInvestigate2025-Q398.303.16—Buyer-sourced0PASS
AX-2025-018600MK-677 (Ibutamoren mesylate)QYBQYB-2503-W5265Kestrel2025-Q399.934.8195.8Buyer-sourced1FAIL
AX-2025-018408DihexaWWBWWB-2507-N1598Janoshik2025-Q399.798.96—Buyer-sourced0PASS
AX-2025-020579TirzepatideSSASSA-2502-D7226Medutest2025-Q397.886.6789.7Buyer-sourced2MARGINAL
AX-2025-020450Melanotan IIKPKP-2508-J5271VendorInvestigate2025-Q398.306.60—Buyer-sourced0FAIL
AX-2025-020242RetatrutideGGPepsGGPE-2508-E1731Janoshik2025-Q398.372.2897.3Supplier-supplied0PASS
AX-2025-020226TirzepatideGGPepsGGPE-2502-J1624Medutest2025-Q398.575.9698.9Buyer-sourced0PASS
AX-2025-018945RetatrutideASYASY-{CAT}-1860Janoshik2025-Q398.255.7799.0Buyer-sourced0PASS
AX-2025-018731SS-31 (Elamipretide)QSCQSC-2502-M6829Kestrel2025-Q398.914.57—Buyer-sourced1MARGINAL
AX-2025-018630TirzepatideQSCQSC-2502-P5432Janoshik2025-Q398.312.2592.2Buyer-sourced0PASS
AX-2025-020627SemaglutideGL BiochemGLBI-2505-V7913Janoshik2025-Q398.334.51—Supplier-supplied1MARGINAL
AX-2025-019227CJC-1295 (no DAC)AMBAMB-2507-A5471Janoshik2025-Q399.323.12—Buyer-sourced0PASS